EARLY TAVR

Evaluation of Transcatheter Aortic Valve Replacement (TAVR) compared to surveillance for patients with asymptomatic severe aortic stenosis.

Type: Device trial

Principal Investigator: Sergio Waxman, MD (NBIMC) 

Trial is open for enrollment

For inquiries, call (973) 926-6938 (NBIMC) 

• Newark Beth Israel Medical Center